Rchr
J-GLOBAL ID：202101010115113169
Update date: Jan. 31, 2024
Miyake Naomi
ミヤケ ナオミ | Miyake Naomi
Affiliation and department：
Job title：
Assistant Professor
Research field (2)：
Tumor biology
, Tumor diagnostics and therapeutics
Research keywords (5)：
Tumor immunity
, Infectious disease immunization
, lymphocyte
, discovery of new medicines
, antibody
Research theme for competitive and other funds (4)：
- 2021 - 2024 COVID-19に対する可溶性ULBP2制御によるNK細胞療法の開発
- 2018 - 2022 Development of a novel surveillance system integrating local and global AMR information
- 2014 - 2018 A novel therapy for sepsis by regulating soluble ULBP2
- 2014 - 2018 Development of the new clinical cure to overcome pemetrexed tolerance for malignant pleural mesothelioma
Papers (7)：
-
Naomi Miyake, Hiroki Chikumi, Kosuke Yamaguchi, Miyako Takata, Miki Takata, Kensaku Okada, Tsuyoshi Kitaura, Masaki Nakamoto, Akira Yamasaki. Effect of Cetuximab and EGFR Small Interfering RNA Combination Treatment in NSCLC Cell Lines with Wild Type EGFR and Use of KRAS as a Possible Biomarker for Treatment Responsiveness. Yonago acta medica. 2019. 62. 1. 85-93
-
Yukinobu Akamatsu, Shota Morishita, Hiroki Chikumi, Ryo Okamoto, Kensaku Okada, Tsuyoshi Kitaura, Naomi Miyake, Kosuke Yamaguchi, Masaki Nakamoto, Hisashi Shimohiro, et al. Evaluation of antigen-positive toxin-negative enzyme immunoassay results for the diagnosis of toxigenic Clostridium difficile infection. The journal of medical investigation : JMI. 2018. 65. 1.2. 131-135
-
Naomi Miyake, Hiroki Chikumi, Miyako Takata, Masaki Nakamoto, Tadashi Igishi, Eiji Shimizu. Rapamycin induces p53-independent apoptosis through the mitochondrial pathway in non-small cell lung cancer cells. Oncology reports. 2012. 28. 3. 848-54
-
Kosuke Yamaguchi, Hiroki Chikumi, Asuka Shimizu, Miyako Takata, Naoki Kinoshita, Kiyoshi Hashimoto, Masaki Nakamoto, Shinji Matsunaga, Jun Kurai, Naomi Miyake, et al. Diagnostic and prognostic impact of serum-soluble UL16-binding protein 2 in lung cancer patients. Cancer science. 2012. 103. 8. 1405-13
-
Miyako Takata, Hiroki Chikumi, Naomi Miyake, Kaori Adachi, Yasunobu Kanamori, Akira Yamasaki, Tadashi Igishi, Naoto Burioka, Eiji Nanba, Eiji Shimizu. Lack of AKT activation in lung cancer cells with EGFR mutation is a novel marker of cetuximab sensitivity. Cancer biology & therapy. 2012. 13. 6. 369-78
ｍore...
Patents (2)：
Education (1)：
- 2010 - 2014 Tottori University Faculty of Medicine School of Medicine
Work history (1)：
- 2018/04 - 現在 Tottori University Faculty of Medicine Assistant Professor
Association Membership(s) (2)：
The molecular Biology Society of Japan
, Japan lung cancer society
